Literature DB >> 29335749

Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.

Vikas Malik1,2, Dennis Zimmer1,2, Ralf Jauch3,4.   

Abstract

The POU (Pit-Oct-Unc) protein family is an evolutionary ancient group of transcription factors (TFs) that bind specific DNA sequences to direct gene expression programs. The fundamental importance of POU TFs to orchestrate embryonic development and to direct cellular fate decisions is well established, but the molecular basis for this activity is insufficiently understood. POU TFs possess a bipartite 'two-in-one' DNA binding domain consisting of two independently folding structural units connected by a poorly conserved and flexible linker. Therefore, they represent a paradigmatic example to study the molecular basis for the functional versatility of TFs. Their modular architecture endows POU TFs with the capacity to accommodate alternative composite DNA sequences by adopting different quaternary structures. Moreover, associations with partner proteins crucially influence the selection of their DNA binding sites. The plentitude of DNA binding modes confers the ability to POU TFs to regulate distinct genes in the context of different cellular environments. Likewise, different binding modes of POU proteins to DNA could trigger alternative regulatory responses in the context of different genomic locations of the same cell. Prominent POU TFs such as Oct4, Brn2, Oct6 and Brn4 are not only essential regulators of development but have also been successfully employed to reprogram somatic cells to pluripotency and neural lineages. Here we review biochemical, structural, genomic and cellular reprogramming studies to examine how the ability of POU TFs to select regulatory DNA, alone or with partner factors, is tied to their capacity to epigenetically remodel chromatin and drive specific regulatory programs that give cells their identities.

Entities:  

Keywords:  Cellular reprogramming; POU; Pioneer TFs; Transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 29335749     DOI: 10.1007/s00018-018-2748-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  273 in total

1.  Skn-1a (Pou2f3) specifies taste receptor cell lineage.

Authors:  Ichiro Matsumoto; Makoto Ohmoto; Masataka Narukawa; Yoshihiro Yoshihara; Keiko Abe
Journal:  Nat Neurosci       Date:  2011-05-15       Impact factor: 24.884

2.  Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence.

Authors:  T G Parslow; D L Blair; W J Murphy; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains.

Authors:  R G Clerc; L M Corcoran; J H LeBowitz; D Baltimore; P A Sharp
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

4.  Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.

Authors:  Takao Kuroda; Masako Tada; Hiroshi Kubota; Hironobu Kimura; Shin-ya Hatano; Hirofumi Suemori; Norio Nakatsuji; Takashi Tada
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.

Authors:  Su-Yi Tsai; Carlos Clavel; Soo Kim; Yen-Sin Ang; Laura Grisanti; Dung-Fang Lee; Kevin Kelley; Michael Rendl
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

6.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

7.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

8.  Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.

Authors:  Yuanji Lin; Ying Yang; Weihua Li; Qi Chen; Jie Li; Xiao Pan; Lina Zhou; Changwei Liu; Chunsong Chen; Jianqin He; Hongcui Cao; Hangping Yao; Li Zheng; Xiaowei Xu; Zongping Xia; Jiangtao Ren; Lei Xiao; Lanjuan Li; Binghui Shen; Honglin Zhou; Ying-Jie Wang
Journal:  Mol Cell       Date:  2012-10-04       Impact factor: 17.970

9.  Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter.

Authors:  I Kemler; E Schreiber; M M Müller; P Matthias; W Schaffner
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  18 in total

1.  Pou4f1 Defines a Subgroup of Type I Spiral Ganglion Neurons and Is Necessary for Normal Inner Hair Cell Presynaptic Ca2+ Signaling.

Authors:  Hanna E Sherrill; Philippe Jean; Elizabeth C Driver; Tessa R Sanders; Tracy S Fitzgerald; Tobias Moser; Matthew W Kelley
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

2.  OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity.

Authors:  Ashley S Doane; Chi-Shuen Chu; Dafne Campigli Di Giammartino; Martín A Rivas; Johannes C Hellmuth; Yanwen Jiang; Nevin Yusufova; Alicia Alonso; Robert G Roeder; Effie Apostolou; Ari M Melnick; Olivier Elemento
Journal:  Nat Immunol       Date:  2021-09-23       Impact factor: 25.606

3.  OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.

Authors:  Xiaoli S Wu; Xue-Yan He; Jonathan J Ipsaro; Yu-Han Huang; Jonathan B Preall; David Ng; Yan Ting Shue; Julien Sage; Mikala Egeblad; Leemor Joshua-Tor; Christopher R Vakoc
Journal:  Nature       Date:  2022-05-16       Impact factor: 69.504

4.  Establishment of resveratrol and its derivatives as neuroprotectant against monocrotophos-induced alteration in NIPBL and POU4F1 protein through molecular docking studies.

Authors:  Ruchi Yadav; Prachi Srivastava
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-30       Impact factor: 4.223

Review 5.  Tuft Cells-Systemically Dispersed Sensory Epithelia Integrating Immune and Neural Circuitry.

Authors:  Claire E O'Leary; Christoph Schneider; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2018-10-31       Impact factor: 28.527

Review 6.  Regulation of immune responses by tuft cells.

Authors:  Christoph Schneider; Claire E O'Leary; Richard M Locksley
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

7.  Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering.

Authors:  Daisylyn Senna Tan; Yanpu Chen; Ya Gao; Anastasia Bednarz; Yuanjie Wei; Vikas Malik; Derek Hoi-Hang Ho; Mingxi Weng; Sik Yin Ho; Yogesh Srivastava; Sergiy Velychko; Xiaoxiao Yang; Ligang Fan; Johnny Kim; Johannes Graumann; Gary D Stormo; Thomas Braun; Jian Yan; Hans R Schöler; Ralf Jauch
Journal:  Mol Biol Evol       Date:  2021-06-25       Impact factor: 16.240

8.  Hierarchical reactivation of transcription during mitosis-to-G1 transition by Brn2 and Ascl1 in neural stem cells.

Authors:  Mário A F Soares; Diogo S Soares; Vera Teixeira; Abeer Heskol; Raul Bardini Bressan; Steven M Pollard; Raquel A Oliveira; Diogo S Castro
Journal:  Genes Dev       Date:  2021-06-24       Impact factor: 11.361

9.  Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing.

Authors:  Veeramohan Veerapandian; Jan Ole Ackermann; Yogesh Srivastava; Vikas Malik; Mingxi Weng; Xiaoxiao Yang; Ralf Jauch
Journal:  Stem Cell Reports       Date:  2018-08-02       Impact factor: 7.765

Review 10.  Biological importance of OCT transcription factors in reprogramming and development.

Authors:  Kee-Pyo Kim; Dong Wook Han; Johnny Kim; Hans R Schöler
Journal:  Exp Mol Med       Date:  2021-06-11       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.